share_log

广济药业(000952.SZ)发布上半年业绩,净亏损1.07亿元

Hubei Guangji Pharmaceutical (000952.SZ) released its performance for the first half of the year, with a net loss of 107 million yuan.

Zhitong Finance ·  Aug 29, 2024 05:33

Hubei Guangji Pharmaceutical (000952.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue...

According to the report, Hubei Guangji Pharmaceutical (000952.SZ) published its semi-annual report for 2024. During the reporting period, the company achieved revenue of 0.296 billion yuan, a decrease of 13.80% compared to the same period last year. The net loss attributable to shareholders of the listed company was 0.107 billion yuan, and the net loss after deducting non-recurring gains and losses attributable to shareholders of the listed company was 0.116 billion yuan. The basic loss per share was 0.3014 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment